Skip to main content

Table 3 Laboratory findings in treated and untreated subjects of the elderly group

From: Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional study

Study GroupNot treated with any lipid-lowering medicationTreated with any lipid-lowering medicationP
Total Number (n)/Percentage (%)1357 (83.2%)273 (16.8%) 
Male46.6%58.4 %<0.01
Current smoker9.0%10.8%0.338
Consultation of a general practitioner during the last 3 months58.3%70.5%<0.01
Arterial Hypertension (systolic BP >=140 mmHg and/or diastolic BP >=90 mmHg)70.5%83.2%<0.01
Diabetes mellitus9.1%22.9%<0.01
Chronic kidney disease (GFR <= 60mL/min/1,73m2)6.7%12.8%<0.01
Coronary heart disease or equivalent4.2%24.0%<0.01
Laboratory findings
Total cholesterol, median (IQR), mmol/L5.7 (5.0 – 6.3)4.8 (4.2 – 5.4)<0.01
LDL-Cholesterol, median (IQR), mmol/L3.5 (2.9 – 4.1)2.6 (2.1 – 3.2)<0.01
HDL-Cholesterol, median (IQR), all, mmol/L1.6 (1.3 – 1.9)1.5 (1.2 – 1.8)<0.01
HDL-Cholesterol, median (IQR), by sex, mmol/Lfemale 1.8 (1.5–2.1)male1.4 (1.1-1.7)female 1.7 (1.4-2.0)male 1.4 (1.1-1.6)0.04/ <0.16
Lipoprotein(a), median (IQR), mg/dL11.0 (4.2 – 31.9)11.0 (5.0 – 41.5)0.163
Triglycerides, median (IQR), mmol/L1.1 (0.8 – 1.5)1.2 (0.9 – 1.7)<0.01
LDL-C at target, ESC-Guidelines5.6%16.5%<0.01
  1. Abbreviations: BP: blood pressure, ESC: European Society of Cardiology, GFR: glomerular filtration rate, HDL: high density lipoprotein, IQR: interquartile range, LDL: low density lipoprotein, Lp(a): Lipoprotein(a), SD: standard deviation